Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Genetics,Molecular Biology
Reference61 articles.
1. Siegel RL, Miller KD, Jemal A . Cancer statistics, 2016. CA Cancer J Clin 2016; 66: 7–30.
2. Neesse A, Michl P, Frese KK, Feig C, Cook N, Jacobetz MA et al. Stromal biology and therapy in pancreatic cancer. Gut 2011; 60: 861–868.
3. Goldstein D, El-Maraghi RH, Hammel P, Heinemann V, Kunzmann V, Sastre J et al. nab-Paclitaxel plus gemcitabine for metastatic pancreatic cancer: long-term survival from a phase III trial. J Natl Cancer Inst 2015; 107: dju413.
4. Von Hoff DD, Ervin T, Arena FP, Chiorean EG, Infante J, Moore M et al. Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine. N Engl J Med 2013; 369: 1691–1703.
5. Rowe RG, Sheikh R, Weiss SJ, Walsh N, Clynes M, O’Connor R et al. Challenges of drug resistance in the management of pancreatic cancer. Cancer Epidemiol Biomarkers Prevent 2000; 9: 1647–1661.
Cited by
78 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献